Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3005 (LINC03005) is classified as a human long intergenic non-coding RNA (lincRNA)[1]. It does not encode a protein but, as a member of the lincRNA family, it could potentially regulate gene expression through mechanisms such as chromatin remodeling, transcriptional regulation, or RNA-protein interactions; however, specific functions or disease associations for LINC03005 itself have not been described in high-quality, curated sources as of the present date[1][5][7][9]. LINC03005 is not considered a canonical therapeutic target, and there are no known drugs, biomarkers, or disease associations specific to this RNA gene. Its sequence and genomic locus are primarily reported in gene databases, not in the functional literature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3005 (LINC03005).